Edition:
United States

La Jolla PharmaAnnounces Launch Of Giapreza In United States


Thursday, 22 Mar 2018 04:01pm EDT 

March 22 (Reuters) - La Jolla Pharmaceutical Co ::LA JOLLA PHARMACEUTICAL COMPANY ANNOUNCES LAUNCH OF GIAPREZA™ (ANGIOTENSIN II) IN THE UNITED STATES.LA JOLLA PHARMACEUTICAL CO - GIAPREZA IS AVAILABLE IN 1 ML SINGLE-DOSE VIALS, EACH CONTAINING 2.5 MG OF ANGIOTENSIN II.